{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:20:59Z","timestamp":1774412459246,"version":"3.50.1"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154704","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:42:06Z","timestamp":1689997326000},"page":"154704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma"],"prefix":"10.1016","volume":"248","author":[{"given":"Mohamed A.","family":"Elkady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr Mohamed","family":"Yehia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed G.E.","family":"Elsakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourhan M.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elshafei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy Y.","family":"Elkhawaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud Mohamed","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham A.","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maghawry","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein M.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba M.","family":"Midan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moataz B.","family":"Zewail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib1","first-page":"275","article-title":"Chimeric antigen receptor T\u2010cell therapy in multiple myeloma: a comprehensive review of current data and implications for clinical practice","volume":"73","author":"Parikh","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.prp.2023.154704_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0268-960X(10)70003-5","article-title":"Multiple myeloma: biology of the disease","volume":"24","author":"Mahindra","year":"2010","journal-title":"Blood Rev."},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib3","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1022268103136","article-title":"Myeloma and race: a review of the literature","volume":"22","author":"Benjamin","year":"2003","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib6","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154704_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102996","article-title":"Epigenetic aberrations in multiple myeloma","author":"Caprio","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib8","first-page":"175","article-title":"Extracellular\/circulating microRNAs: release mechanisms, functions and challenges","volume":"10","author":"Sohel","year":"2016","journal-title":"Achiev. Life Sci."},{"key":"10.1016\/j.prp.2023.154704_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154704_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: a spotlight on signaling pathways interplay\u2014a review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154704_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154704_bib13","article-title":"Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review","author":"Ismail","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154704_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Ismail","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance \u2013 a focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: a focus on signaling pathways interplay","author":"Doghish","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib18","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib20","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013an emphasis on the interaction of signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121667","article-title":"An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer","author":"Fathi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154704_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-a review","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib26","article-title":"A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154457","article-title":"miRNAs as potential game-changers in head and neck cancer: future clinical and medicinal uses","author":"El-Mahdy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121697","article-title":"Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats","volume":"323","author":"Allam","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154704_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105195","article-title":"Impact of the mother's gut microbiota on infant microbiome and brain development","author":"Mady","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.prp.2023.154704_bib31","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: signaling pathways interplay","author":"Elshaer","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154557","article-title":"miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11","author":"Elrebehy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib34","article-title":"miRNAs as potential game-changers in retinoblastoma: future clinical and medicinal uses","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer \u2013 a focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib36","article-title":"miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance","author":"Ahmed","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib37","article-title":"The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors - particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154665","article-title":"miRNAs orchestration of adrenocortical carcinoma - particular emphasis on diagnosis, progression and drug resistance","author":"El-Dakroury","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib40","article-title":"The potential role of miRNAs in the pathogenesis of gallbladder cancer - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: potential therapeutic and clinical applications","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib42","article-title":"miRNAs as potential game-changers in bone diseases: future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154624","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 a focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154704_bib45","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154704_bib46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154704_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154704_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154704_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154704_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib53","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib54","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.154704_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.prp.2023.154704_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154704_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154704_bib59","unstructured":"K.I. Eissa, M.M. Kamel, L.W. Mohamed, A.S. Doghish, R. Alnajjar, A.A. Al\u2010Karmalawy, A.E. Kassab, Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease, Drug Dev. Res."},{"key":"10.1016\/j.prp.2023.154704_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating microRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2023.154704_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154183","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway (s) and clinical outcome (s) association","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154704_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106382","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib64","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Noncoding RNA Res."},{"issue":"7014","key":"10.1016\/j.prp.2023.154704_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154704_bib66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","volume":"66","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib67","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like","volume":"1","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.154704_bib68","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154704_bib69","first-page":"1","article-title":"Regulation of microRNAs","author":"Ergin","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"7149","key":"10.1016\/j.prp.2023.154704_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.154704_bib71","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib72","first-page":"1","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154704_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: a review","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib76","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"issue":"7795","key":"10.1016\/j.prp.2023.154704_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154704_bib78","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.prp.2023.154704_bib79","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154704_bib80","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib82","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154704_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","volume":"303","author":"Al-Noshokaty","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154704_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib86","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia-and microRNA-induced metabolic reprogramming of tumor-initiating cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib87","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3892\/ol.2020.11579","article-title":"MiR\u2011181a functions as an oncogene by regulating CCND1 in multiple myeloma","volume":"20","author":"Yan","year":"2020","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib88","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1541-7786.MCR-17-0606","article-title":"Runx2 suppression by miR-342 and miR-363 inhibits multiple myeloma progression","volume":"16","author":"Gowda","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib89","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/2211-5463.13063","article-title":"microRNA-637 promotes apoptosis and suppresses proliferation and autophagy in multiple myeloma cell lines via NUPR1","volume":"11","author":"Chen","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3892\/ijmm.2020.4841","article-title":"Downregulation of microRNA\u201125\u20133p inhibits the proliferation and promotes the apoptosis of multiple myeloma cells via targeting the PTEN\/PI3K\/AKT signaling pathway","volume":"47","author":"Zi","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib91","first-page":"10001","article-title":"Effects of microRNA\u201120a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN\/PI3K\/AKT signaling pathway","volume":"15","author":"Jiang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"27","key":"10.1016\/j.prp.2023.154704_bib92","first-page":"1","article-title":"MicroRNA-338\u20133p inhibits proliferation and promotes apoptosis of multiple myeloma cells through targeting cyclin-dependent kinase 4","volume":"4","author":"Cao","year":"2019","journal-title":"Oncol Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib93","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.21037\/tcr-20-3490","article-title":"The microRNA miR-19a-3p suppresses cell growth, migration, and invasion in multiple myeloma via the Wnt\/\u03b2-catenin pathway","volume":"10","author":"Wei","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2023.154704_bib94","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1166\/jbt.2022.3196","article-title":"MicroRNA-429 regulates invasion and migration of multiple myeloma cells via Bmi1\/AKT pathway","volume":"12","author":"Yang","year":"2022","journal-title":"J. Biomater. Tissue Eng."},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib95","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1078-0432.CCR-15-0489","article-title":"A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells","volume":"22","author":"Gulla","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"31","key":"10.1016\/j.prp.2023.154704_bib96","doi-asserted-by":"crossref","first-page":"31134","DOI":"10.18632\/oncotarget.5290","article-title":"HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide","volume":"6","author":"Canella","year":"2015","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.prp.2023.154704_bib97","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.4161\/cc.25251","article-title":"Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression","volume":"12","author":"Murray","year":"2013","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib98","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3892\/ijo.2016.3830","article-title":"Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and-resistant cell lines","volume":"50","author":"Hentati-Kallel","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2023.154704_bib99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","article-title":"Matrix metalloproteinase (MMP)-2\u20131306\u2009C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients","volume":"5","author":"Elkady","year":"2016","journal-title":"Gene Rep."},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib100","first-page":"953","article-title":"Protective effect of proanthocyanidins on nephrotoxicity induced by antitumor dose of cisplatin in ehrlich solid tumor-bearing mice","volume":"40","author":"Salman","year":"2014","journal-title":"Arab. J. Lab. Med."},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib101","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/pharmaceutics15071906","article-title":"Comparison of bovine- and porcine-derived decellularized biomaterials: promising platforms for tissue engineering applications","volume":"15","author":"El-Husseiny","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.prp.2023.154704_bib102","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/1568009616666160203114140","article-title":"miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF","volume":"16","author":"Zhang","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib103","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3109\/10428194.2011.591004","article-title":"Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation","volume":"52","author":"Wang","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ph16010111","article-title":"Review on bortezomib resistance in multiple myeloma and potential role of emerging technologies","volume":"16","author":"Kozalak","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/leu.2016.325","article-title":"Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma","volume":"31","author":"Qin","year":"2017","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib106","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154704_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154704_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib109","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154704_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106729","article-title":"Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: synthesis, biological evaluation and molecular dynamics investigations","author":"Azmy","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.prp.2023.154704_bib111","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.154704_bib112","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.154704_bib113","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib114","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.prp.2023.154704_bib115","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3109\/10428194.2011.576791","article-title":"Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression","volume":"52","author":"Hao","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib116","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3892\/or.2016.5318","article-title":"hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10","volume":"37","author":"Xi","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2023.154704_bib117","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12253-015-0035-4","article-title":"Study on the association between miRNA-202 expression and drug sensitivity in multiple myeloma cells","volume":"22","author":"Shen","year":"2016","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib118","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.ygeno.2020.03.022","article-title":"Effect of scopoletin on phagocytic activity of U937-derived human macrophages: Insights from transcriptomic analysis","volume":"112","author":"Alkorashy","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.prp.2023.154704_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2022.101972","article-title":"Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression","volume":"49","author":"El-Ashmawy","year":"2022","journal-title":"Food Biosci."},{"issue":"11","key":"10.1016\/j.prp.2023.154704_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.175","article-title":"miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1","volume":"3","author":"Amodio","year":"2012","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.prp.2023.154704_bib121","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","article-title":"MIR145\u20133p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4","volume":"16","author":"Wu","year":"2020","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib122","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/cancers11020236","article-title":"Replacement of miR-155 elicits tumor suppressive activity and antagonizes bortezomib resistance in multiple myeloma","volume":"11","author":"Amodio","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib123","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41419-018-1219-0","article-title":"LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p","volume":"3p","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib124","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695525","article-title":"Beyond circulating microRNA biomarkers: urinary microRNAs in ovarian and breast cancer","volume":"39","author":"Gasparri","year":"2017","journal-title":"Tumor Biol."},{"issue":"16","key":"10.1016\/j.prp.2023.154704_bib125","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib126","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Kubiczkova","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib127","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00432-019-02896-1","article-title":"Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma","volume":"145","author":"Gupta","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib128","first-page":"4001","article-title":"The diagnostic and prognostic value of plasma microRNA\u2011125b\u20115p in patients with multiple myeloma","volume":"16","author":"Jiang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clml.2017.05.010","article-title":"Expression of peripheral blood miRNA-720 and miRNA-1246 can be used as a predictor for outcome in multiple myeloma patients","volume":"17","author":"Ren","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ejh.12124","article-title":"Aberrant microRNA expression in multiple myeloma","volume":"91","author":"Dimopoulos","year":"2013","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib131","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1515\/cclm-2015-1108","article-title":"Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma","volume":"55","author":"Shen","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib132","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12032-014-0219-x","article-title":"Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma","volume":"31","author":"Qu","year":"2014","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib133","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10428194.2012.704030","article-title":"Serum miR-29a as a marker of multiple myeloma","volume":"54","author":"Sevcikova","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib134","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2645","article-title":"Genetic prognostic and predictive markers in colorectal cancer","volume":"9","author":"Walther","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2023.154704_bib135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1568009617666170330154756","article-title":"Immunomodulatory activity of MicroRNAs: potential implications for multiple myeloma treatment","volume":"17","author":"Botta","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"issue":"35","key":"10.1016\/j.prp.2023.154704_bib136","doi-asserted-by":"crossref","first-page":"38270","DOI":"10.18632\/oncotarget.5681","article-title":"MicroRNA-15a\/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.prp.2023.154704_bib137","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/leu.2011.147","article-title":"MicroRNA signatures characterize multiple myeloma patients","volume":"25","author":"Corthals","year":"2011","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.prp.2023.154704_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.358","article-title":"LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN\/PI3K\/AKT pathway in multiple myeloma","volume":"8","author":"Yang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2023.154704_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmt.2022.101560","article-title":"Smart\/stimuli-responsive hydrogels: state-of-the-art platforms for bone tissue engineering","author":"El-Husseiny","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.prp.2023.154704_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1174075","article-title":"Stimuli-responsive hydrogels: smart state of-the-art platforms for cardiac tissue engineering","volume":"11","author":"El-Husseiny","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"10.1016\/j.prp.2023.154704_bib141","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.3390\/ijms24087513","article-title":"Impact of adipose tissue depot harvesting site on the multilineage induction capacity of male rat adipose-derived mesenchymal stem cells: an in vitro study","volume":"24","author":"El-Husseiny","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.prp.2023.154704_bib142","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.29199","article-title":"Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma","volume":"136","author":"Hao","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib143","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1745-6150-6-23","article-title":"MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival","volume":"6","author":"Chi","year":"2011","journal-title":"Biol. Direct"},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib144","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bjh.12394","article-title":"Improved risk stratification in myeloma using a microRNA-based classifier","volume":"162","author":"Wu","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib145","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1111\/jcmm.15035","article-title":"PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7\/NF-\u03baB pathway in multiple myeloma","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib146","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2174\/13894501113149990186","article-title":"From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario","volume":"14","author":"Rossi","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"33","key":"10.1016\/j.prp.2023.154704_bib147","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib148","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.31041","article-title":"MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling","volume":"142","author":"Tang","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3727\/096504018X15213031799835","article-title":"MicroRNA-338-3p inhibits proliferation and promotes apoptosis of multiple myeloma cells through targeting cyclin-dependent kinase 4","volume":"27","author":"Cao","year":"2018","journal-title":"Oncol. Res."},{"issue":"17","key":"10.1016\/j.prp.2023.154704_bib150","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154704_bib151","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/erm.10.11","article-title":"Micromarkers: miRNAs in cancer diagnosis and prognosis","volume":"10","author":"Ferracin","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib152","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.prp.2023.154704_bib153","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/bjc.2012.525","article-title":"Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma","volume":"107","author":"Jones","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib154","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2011.51","article-title":"Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders","volume":"2","author":"Yoshizawa","year":"2012","journal-title":"Blood Cancer J."},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib155","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.18632\/oncotarget.15059","article-title":"A panel of microRNA signature in serum for colorectal cancer diagnosis","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.prp.2023.154704_bib156","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1158\/1078-0432.CCR-12-3401","article-title":"Identification of circulating microRNA signatures for breast cancer detection","volume":"19","author":"Chan","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.prp.2023.154704_bib157","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/bjc.2014.119","article-title":"A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer","volume":"110","author":"Zhu","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154704_bib158","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0004563213501155","article-title":"miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients","volume":"51","author":"Yu","year":"2013","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.prp.2023.154704_bib159","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s12032-012-0210-3","article-title":"Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma","volume":"29","author":"Huang","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2023.154704_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207539","article-title":"Role of microRNAs in diagnosis, prognosis and management of multiple myeloma","author":"Soliman","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.prp.2023.154704_bib161","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0806202105","article-title":"MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis","volume":"105","author":"Pichiorri","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"41","key":"10.1016\/j.prp.2023.154704_bib162","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41388-018-0359-0","article-title":"Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib163","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/leu.2017.91","article-title":"The emerging roles of tumor-derived exosomes in hematological malignancies","volume":"31","author":"Boyiadzis","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.prp.2023.154704_bib164","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/or.2016.5304","article-title":"MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway","volume":"37","author":"Xu","year":"2017","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.prp.2023.154704_bib165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/ejh.12870","article-title":"Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma","volume":"98","author":"de la Puente","year":"2017","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib166","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1080\/13880209.2022.2136208","article-title":"Ameliorative effect of chitosan nanoparticles against carbon tetrachloride-induced nephrotoxicity in Wistar rats","volume":"60","author":"Nomier","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.prp.2023.154704_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122006","article-title":"Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation","volume":"624","author":"Zewail","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2023.154704_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121303","article-title":"Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates exceptional efficiency in amelioration of peptic ulcer","volume":"611","author":"El-Dakroury","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2023.154704_bib169","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib170","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1038\/srep17579","article-title":"Delivery of miR-34a by chitosan\/PLGA nanoplexes for the anticancer treatment of multiple myeloma","volume":"5","author":"Cosco","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154704_bib171","article-title":"Repression of multiple myeloma cell growth in vivo by single-wall carbon nanotube (SWCNT)-delivered MALAT1 antisense oligos","volume":"142","author":"Lin","year":"2018","journal-title":"JoVE J. Vis. Exp."},{"issue":"25","key":"10.1016\/j.prp.2023.154704_bib172","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215711120","article-title":"In vivo bone marrow microenvironment siRNA delivery using lipid\u2013polymer nanoparticles for multiple myeloma therapy","volume":"120","author":"Guimar\u00e3es","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2023.154704_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109712","article-title":"Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C\/Apaf-1\/Caspase-9\/Caspase-3 signaling pathway in vitro","volume":"122","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154704_bib174","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/mt.2012.94","article-title":"Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-\u03baB activity and tumor growth in murine models of multiple myeloma","volume":"20","author":"Taylor","year":"2012","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/ac202749p","article-title":"MicroRNA conjugated gold nanoparticles and cell transfection","volume":"84","author":"Crew","year":"2012","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.prp.2023.154704_bib176","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41375-019-0540-7","article-title":"BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications","volume":"34","author":"Bae","year":"2020","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.prp.2023.154704_bib177","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1021\/acs.molpharmaceut.8b00584","article-title":"Anti-multiple myeloma activity of nanobody-based anti-CD38 chimeric antigen receptor T cells","volume":"15","author":"An","year":"2018","journal-title":"Mol. Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823004041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823004041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:42:35Z","timestamp":1774410155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823004041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":177,"alternative-id":["S0344033823004041"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154704","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154704"}}